Non-small-cell lung cancer progression after first-line chemotherapy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Oncology
Link
http://link.springer.com/content/pdf/10.1007/s11864-002-0041-0.pdf
Reference25 articles.
1. Greenlee RT, Murray T, Bolden S, Wingo S: Cancer Statistics 2000. CA Cancer J Clin 2000, 50:7–33.
2. American Society of Clinical Oncology: Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. J Clin Oncol 1997, 15:2996–3018.
3. Marino P, Pampallona S, Preatoni A, et al.: Chemotherapy vs supportive care in advanced non-small-cell lung cancer: results of meta-analysis of the literature. Chest 1994, 106:861–865.
4. Non-Small-Cell Lung Cancer Collaborative Group: Chemotherapy in non-small-cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 1995, 311:899–909.
5. Rapp E, Pater JL, Willan A, et al.: Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer: a report of a Canadian multicenter randomized trial. J Clin Oncol 1998, 6:633–641.
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Novel HDAC11 inhibitors suppress lung adenocarcinoma stem cell self-renewal and overcome drug resistance by suppressing Sox2;Scientific Reports;2020-03-13
2. Regulation Mechanism of MicroRNAs in Non-Small Cell Lung Cancer;Current Pharmaceutical Design;2018-02-12
3. TASK‑1 induces gefitinib resistance by promoting cancer initiating cell formation and epithelial‑mesenchymal transition in lung cancer;Experimental and Therapeutic Medicine;2017-11-01
4. Gli1-Mediated Regulation of Sox2 Facilitates Self-Renewal of Stem-Like Cells and Confers Resistance to EGFR Inhibitors in Non–Small Cell Lung Cancer;Neoplasia;2015-07
5. YAP1 Regulates OCT4 Activity and SOX2 Expression to Facilitate Self-Renewal and Vascular Mimicry of Stem-Like Cells;Stem Cells;2015-05-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3